🧠 Food for thought

Implications, context, and why it matters.

Missing valuation context behind the first-day drops

• Price moves need valuation context. WeRide priced its Hong Kong shares at HK$27.10, about a 4% discount to its Nasdaq close 1, yet the stock still opened lower in Hong Kong.
• Pony.ai raised about US$863 million (approximately HK$6.7 billion) 1 and still fell at the open. WeRide’s American Depositary Shares (ADSs) have dropped about 30% since their October 2024 debut 1, and recent US sessions were weak for both names, which kept Hong Kong discounts from offsetting doubts on autonomous-driving commercialization timelines.
• Sparse disclosures limit valuation checks. The lack of revenue, losses, or cash-burn rates (how quickly a company spends its cash) makes it hard to judge whether market caps near US$3.4 billion for WeRide 1 look reasonable or whether premiums are being corrected.

Opportunity in Hong Kong’s surging IPO pipeline for investors and service providers

• H1 2025 put Hong Kong on top for IPO funds with US$14.1 billion 2. The surge gives institutional investors reasons to track the Hong Kong Exchanges and Clearing (HKEX) pipeline, watching listing hearing dates, cornerstone allocations (shares reserved for pre-committed anchor investors), and pricing announcements.
• Eight A-to-H IPOs priced in H1 2025 raised US$10.1 billion, and Contemporary Amperex Technology Co. Limited (CATL) sold US$5.3 billion, which lifted average aftermarket gains for the largest deals by 14% as of June 30 2. Investors can focus on healthcare at US$5.8 billion and TMT at US$13.7 billion, as AI tailwinds supported issuance 2.
• Legal advisors, underwriters, and financial-technology platforms can prepare for deal flow through new HKEX initiatives 2. The Technology Enterprises Channel launched in May 2025 to speed specialist tech and biotech listings and is shortening approval timelines while widening the issuer base 2.